# Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography

> **NCT03783832** · — · UNKNOWN · sponsor: **Aquitania Opthalmologica** · enrollment: 48 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **OTHER:** OCT ANGIOGRAPHY DATA

## Key facts

- **NCT ID:** NCT03783832
- **Lead sponsor:** Aquitania Opthalmologica
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-19
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2018-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03783832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03783832, "Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03783832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*